In addition, induction of SOCS1 and SOCS3 to counteract the IFN antiviral response is also observed in other viral infections, such as SARS-CoV [168], herpes simplex virus 1 [169], respiratory syncytial virus [170], HCV [171], and IAV [172], which implies that miR-30a-5p may have a wide-spectrum antiviral capacity and deserves further investigation in the future. Here, IFNA1 is linked to viral infectious disease.